Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FiX-IT: Teriparatide for Atypical Femoral Fracture
NCT01705587Phase 4Completed
- Start
- Dec 2012
- Primary completion
- Sep 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of teriparatide in atypical femoral fracture (AFF). Started Dec 2012; status: completed.
02
Drugs
teriparatide
03
Conditions
atypical femoral fracture (AFF)
Beyond the preview
Go deeper on NCT01705587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01705587.